Minnesota Genomics Partnership Commits to 'Defeat' Diabetes in 10 Years | GenomeWeb

By Alex Philippidis

NEW YORK (GenomeWeb News) – The Minnesota Partnership for Biotechnology and Medical Genomics plans to lead a multi-institutional effort to translate diabetes research into improved yet lower-cost treatments, if not a cure, for the disease within 10 years – an effort it projects will require between $250 million and $350 million of public and private funds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.